DLA, Kirkland, Freshfields Advise On £4.5B Deal For Dechra
Veterinary drugmaker Dechra said Friday that it has agreed to be bought for £4.5 billion ($5.6 billion) by Swedish investment group EQT and Abu Dhabi's investment vehicle, in one of the...To view the full article, register now.
Already a subscriber? Click here to view full article